09/25/2024
From ESMO Congress 2024: A Tool to Guide Treatment for Advanced Prostate Cancer
Decipher® Score: A Tool to Guide Treatment for Advanced Prostate Cancer Currently, the standard of care treatment for metastatic hormone-sensitive prostate cancer (mHSPC) includes: Hormone therapy (ADT) + an androgen receptor pathway inhibitor (ARPI) such as enzalutamide or abiraterone ADT + the chemotherapy drug docetaxel ADT + ARPI + docetaxel Which. Read More
09/23/2024
Highlights of ESMO Congress 2024: Promising Treatment Approaches for Advanced Prostate Cancer
Clinicians and researchers gathered earlier this month at the European Society of Medical Oncology Congress 2024 in Barcelona. Hundreds of presentations covered advances in cancer research, including groundbreaking new clinical trial data in prostate cancer. While survival for patients with metastatic hormone-sensitive prostate cancer (mHSPC) and with metastatic castration-resistant prostate cancer. Read More
09/18/2024
Lime-Basil Chicken Thighs with Corn
September marks the end of summer, but we’re not ready to say goodbye just yet. Relish the last bit of the season with Lime-Basil Chicken Thighs with Corn - an easy and delicious dish for those final summer nights. Olive oil is the star ingredient. Healthy fats may reduce the. Read More
09/11/2024
Study Finds Increased Mental Health Needs Upon Prostate Cancer Diagnosis
There isn’t a lot known about mental health in relation to prostate cancer. However, a recent study of nearly 14,000 men conducted by the University of South Australia provides additional insight, suggesting that it could be helpful to incorporate early mental health intervention upon diagnosis. In a press release announcing. Read More
Spanish Guide Confirmation Page
Gracias por su solicitud. Los envíos por correo de PCF pueden tardar entre 3 y 4 semanas. Si tiene alguna pregunta o si necesita más de una copia del título de una guía, contáctenos en [email protected] o llame al 1-310-570-4700. Por favor considere hacer una donación para cubrir el costo. Read More
08/15/2024
Making Sense of PSA After Treatment: Radiation (Part 4)
How do you know if localized prostate cancer is cured? That answer to that question is straightforward for men who undergo radical prostatectomy: in the weeks after surgery, the PSA should become undetectable, falling to less than 0.1. But for men who undergo radiation therapy, it’s more complicated: there is. Read More
08/15/2024
Making Sense of PSA After Treatment: Persistence (Part 3)
If PSA does not go away after prostatectomy, this is called “PSA persistence,” and there are three things that could be causing it, says Weill Cornell Medicine urologist Jim C. Hu, M.D., M.P.H. There could be some normal prostate tissue left behind. “This was more common when we first started. Read More
08/15/2024
Making Sense of PSA After Treatment, Part 2
Let’s say a prostatectomy patient’s first PSA after surgery was less than 0.02 at three months, but at one year is 0.1. “If that patient is high-risk (see Box) to begin with, that’s a pretty clear signal that this particular patient is probably going to have a recurrence,” says Hu. . Read More
08/15/2024
Making Sense of PSA After Treatment: Surgery (Part 1)
In this 4-part series, Weill Cornell Medicine urologist Jim C. Hu, M.D., M.P.H., breaks down what rising or persistent PSA means after treatment for localized prostate cancer, and what you should do next. Part 1: What if PSA Comes Back After Surgery? Part 2: What PSA Number Should Sound the Call to Action? Part 3: PSA Persistence:. Read More
08/15/2024
Making Sense of PSA After Treatment
In this 4-part series, Weill Cornell Medicine urologist Jim C. Hu, M.D., M.P.H., breaks down what rising or persistent PSA means after treatment for localized prostate cancer, and what you should do next. Part 1: What if PSA Comes Back After Surgery? Part 2: What PSA Number Should Sound the. Read More